Clinical Trial Update: GSK2190915A - Bioavailability Study [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of GSK2190915A in asthma patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED